Δ9-Tetrahydrocannabinol-Like Effects of Novel Synthetic Cannabinoids Found on the Gray Market

Behavioural Pharmacology - United States
doi 10.1097/fbp.0000000000000150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Interactions Between Δ9-Tetrahydrocannabinol and Heroin

Behavioural Pharmacology
PsychiatryMental HealthPharmacology
2012English

Acute Human Exposure Assessment to Tetrahydrocannabinol (Δ9‐THC)

EFSA Journal
VeterinaryMicrobiologyFood ScienceAnimal ScienceParasitologyPlant ScienceZoology
2020English

Daily L-Δ9-Tetrahydrocannabinol and Pressing for Hypothalamic Stimulation

Bulletin of the Psychonomic Society
1977English

Tolerance and Dependence to Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Activity Assessments

PLoS ONE
Multidisciplinary
2019English

Δ9-Tetrahydrocannabinol Acts as a Partial Agonist/Antagonist in Mice

Behavioural Pharmacology
PsychiatryMental HealthPharmacology
2012English

Investigating the Effect of Δ9-Tetrahydrocannabinol on Brain-Derived Neurotropic Factor Levels in Depressed Male Rats

2020English

The Antiemetic Interaction of Δ9-Tetrahydrocannabinol When Combined With Tropisetron or Dexamethasone in the Least Shrew

Pharmacology Biochemistry and Behavior
PharmacologyBiochemistryClinical BiochemistryBehavioral NeuroscienceToxicologyBiological Psychiatry
2009English

Do Δ9-Tetrahydrocannabinol Concentrations Indicate Recent Use in Chronic Cannabis Users?

Addiction
MedicinePsychiatryMental Health
2009English

Synthetic Cannabinoids: A Disturbing Trend

Addiction & Addictive Disorders
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy